Navigation Links
Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa®
Date:10/10/2010

e discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses.  Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

Editor's Note: Denosumab administered as a 60 mg single subcutaneous injection every six months has been approved under the trade name Prolia™ in the United States for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia has also been approved in the EU to treat osteoporosis in postmenopausal women at increased risk of fracture and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures. The Prolia trade name may not apply for future indications of denosumab. For full Prolia prescribing information, please visit www.prolia.com.

Denosumab is currently under global regulatory review for the reduction of SREs in patients with advanced cancer. The advanced cancer program is evaluating 120
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Self Regional Healthcare Becomes First in the Southeast to Treat Spine Patients Using Advanced Integrated Operating Room Technology From Brainlab
2. Molecular Detection and Integrated Sciences Announce Distribution Agreement for Detect-Ready™ MRSA Assay in Australia
3. Oridion to Present Results to New Study for the Integrated Pulmonary Index(TM) at ATACCC Conference
4. StatRad Raises the Bar With Fully Integrated Teleradiology Solution
5. Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite
6. Highmark Study Shows Integrated Medical and Pharmacy Benefits Lower Costs, Promote Better Health
7. Stereotaxis and Siemens Promote Integrated Odyssey(TM) Solutions
8. RedVision Announces Integrated Client Workflow Platform: TitleVision2 The Power of Two
9. Texas Instruments unveils fully integrated analog front end for ECG and EEG applications
10. Feintuch Communications Launches Integrated PR and IR Practice for Healthcare and Life Sciences Organizations
11. New York States Largest Integrated Health System Chooses Craneware Revenue Integrity Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... YORK , Sept. 17, 2014 ... Summary GlobalData,s new report, "Germany Gynecological ... data on the Germany Gynecological Devices market. The ... volume (in units) and average prices (in US ... (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices ...
(Date:9/17/2014)... -- Levi & Korsinsky, LLP is investigating Alexza Pharmaceuticals Inc. ... of fiduciary duty by the board of directors of ... here: http://zlk.9nl.com/alexza-pharmaceuticals-alxa . There is no cost or ... stock in Alexza Pharmaceuticals Inc. and wish to obtain ... either via email at ek@zlk.com or by ...
(Date:9/17/2014)... -- Pomerantz LLP is investigating claims on behalf of ... "Company") (NASDAQ: PDLI).  Such investors are advised to contact ... or 888-476-6529, ext. 237. The investigation concerns ... directors have violated Sections 10(b) and 20(a) of the ... September 17, 2014, the Company announced that On September ...
Breaking Medicine Technology:Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDL BioPharma, Inc. - PDLI 2
... Calif., May 24, 2011 AmbiCom Holdings, Inc. (OTCQB: ABHI), ... equipment suppliers, today announced that it has signed a new ... the credit line that was due to expire July 2011. ... $1.3 million from $1.0 million in the previous revolving line ...
... 2011 Systech International®, innovator of Packaging ... Videojet today announced that one of the world,s ... Serialized Product Tracking (SPT) solution on ... manufacturer will employ Systech SPT to meet Brazil,s ...
Cached Medicine Technology:AmbiCom Renews and Expands Line of Credit With East West Bank 2AmbiCom Renews and Expands Line of Credit With East West Bank 3Top Pharmaceutical Manufacturer Selects Systech to Meet Brazil's Anti-Counterfeiting Regulatory Requirements 2Top Pharmaceutical Manufacturer Selects Systech to Meet Brazil's Anti-Counterfeiting Regulatory Requirements 3Top Pharmaceutical Manufacturer Selects Systech to Meet Brazil's Anti-Counterfeiting Regulatory Requirements 4
(Date:9/18/2014)... 18, 2014 CD-adapco, the largest privately ... today announced its new partnership with Ben Ainslie Racing. ... simulation tool, STAR-CCM+® in the design of its racing ... in the 35th America’s Cup taking place in 2017. ... America’s Cup is sustainability, the set of restrictive rules ...
(Date:9/18/2014)... drink less sugar, according to a new study from ... enough, the study goes on to say, as all ... healthier at school , The research suggests a parent,s ... a child,s diet. , The study found Vancouver school ... per cent more likely to eat vegetables during the ...
(Date:9/18/2014)... is available in German . ... Mnchen have won the ,International Space Station Research ... As their prize, the scientists will see the International ... The project involves crystallizing two proteins of the hepatitis ... proteins to the International Space Station is scheduled to ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Relias Learning, the ... and human services markets, today announced it has been named ... growing private companies in America. , In the three-year period ... moved up almost 2,000 spots on the Inc. 5000 list ... , “The industries we serve continue to grow, ...
(Date:9/18/2014)... 18, 2014 According to a new market ... Market - Global Industry Analysis, Size, Share, Growth, Trends and ... market was valued at USD 77607.7 million in 2013 and ... 2014 to 2020, to reach an estimated value of USD ... services market is growing at a rapid pace due to ...
Breaking Medicine News(10 mins):Health News:Ben Ainslie Racing Using STAR-CCM+ Simulation Software to Design 35th America’s Cup Racing Boat 2Health News:Kids eat better if their parents went to college 2Health News:Hepatitis C virus proteins in space 2Health News:Relias Learning Named to Inc. 5000 List for Second Consecutive Year 2Health News:Dialysis Products and Services Market Expected to Reach USD 115.4 Billion Globally in 2020 2Health News:Dialysis Products and Services Market Expected to Reach USD 115.4 Billion Globally in 2020 3Health News:Dialysis Products and Services Market Expected to Reach USD 115.4 Billion Globally in 2020 4
... University of Rochester, New York suggests that the activated ... properties,which until now is being used to treat septic ... stroke. Researchers who conducted the study on mice found ... damage associated with ischemic stroke by preventing apoptosis, a ...
... the British Medical Journal has argued that the cause ... stage could be attributed to coloured toilet disinfectants. Researchers ... cancers detected early can be successfully treated and that ... The National programme// for detection of colorectal cancer suggested ...
... A team of doctors from different specialties, recently joined hands ... patients. Dr. Peter Costantino, an otolaryngologist, about three years ago, ... nasal cavity and right eye socket. According to the American ... neck cancer were diagnosed in 2002. This type of cancer ...
... curvature of the spine diagnosed after the age ten, ... to earlier belief that the condition increases mortality rates ... related to the curvature. Researchers from the University of ... with LIS appear to experience only little physical// impairment ...
... associated with good health and parents world over, have ... However, a recent study in New Zealand has raised ... A study involving 20 countries published in the New ... milk containing the A-1 beta case in protein and ...
... Twisthaler has been launched by Schering-Plough as therapy in ... persistent asthma in patients 12 years of age and ... January and is expected to be launched in the ... Asmanex Twisthaler, a dry powder inhaler, contains the orally// ...
Cached Medicine News:
... offer the physician a new approach to supportive ... The weight simply uses gravity to gently close ... or when the eyelid muscle is relaxed. ... variety of skin tone colors to match a ...
... Heidelberg Multi Color (HMC) ... a microprocessor-controlled precision assessment ... the red/green range (Rayleigh ... (Moreland equation) with integrated ...
... VersaSuite practice management software is ... the business and clinical aspects of ... solution offers support for the financial, ... the eye care professional. Designed as ...
... in our country to provide greater and ... recent government regulations require it. The Access ... your wheelchair-bound patients easy and comfortable access ... to leave their wheelchair. , ,The Access ...
Medicine Products: